Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a suspected or confirmed diagnosis of advanced ovarian, fallopian tube, or peritoneal cancer (stage III or IV, meaning the cancer has spread outside the pelvis).
- You fall into one of these four groups:
- You are newly diagnosed (or suspected) and your doctor has recommended surgery to remove the cancer, but you have not had surgery yet.
- You are newly diagnosed and your doctor needs to perform a keyhole (laparoscopic) procedure to decide whether surgery or chemotherapy first is the right approach for you.
- Your ovarian cancer has come back and your doctor is considering surgery to remove it or confirm the recurrence.
- You have already had chemotherapy before surgery (called neoadjuvant chemotherapy) and your doctor has now recommended surgery, but you have not had it yet.
- You are 18 years of age or older.
- Your doctors (cancer surgeon and medical oncologist) consider you healthy enough to safely have both a needle procedure and your planned surgery.
- Your recent blood test results (taken within 14 days before the study procedure, or 7 days if you are in group 4 above) meet certain safety levels for blood counts and clotting ability.
- If you could become pregnant, you must have a negative pregnancy test before joining.
- You have had a CT scan of your abdomen and pelvis within the past 4 weeks that shows enough detail about your cancer and confirms a safe location for the study device to be placed and later removed during surgery.
- Your tumour is large enough for the study device to be safely placed inside it, without affecting the tissue needed for your diagnosis.
- The tumour where the device will be placed can be safely reached by a needle from outside the body, and can be removed during your planned surgery or keyhole procedure without significantly affecting the operation or your safety.
- You are willing and able to understand and sign a consent form.
- You are willing to have research genetic testing (of both your tumour and inherited genes) and agree to your anonymised genetic data being stored in a national health research database.
Who may not be able to join:
- You have a serious uncontrolled illness, such as an active infection, unstable heart condition, irregular heartbeat, or a mental health or personal situation that would make a biopsy or surgery unsafe.
- You are currently pregnant, due to the radiation involved in imaging and the potential risks of the needle procedure near the baby.
- You have a bleeding or clotting disorder that cannot be corrected and that increases the risk of a needle biopsy or surgery.
- You have significant health risk factors (such as a high risk of blood clots, stroke, or heart attack) that mean it would not be safe for you to stop blood-thinning medication before the procedure, according to standard medical guidelines. (Note: taking low-dose aspirin alone does not disqualify you.)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elizabeth Stover, MD, PhD, Dana-Farber Cancer Institute
Phone: (617) 632-5269
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events as defined in the CTCAE v5.0; Number of implanted microdevices successfully retrieved
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.